Announcements Trials
Browse Landscape

Phase

Phase 3 16Phase 2 14Phase NA 10Phase 1 8Phase 1/2 7Phase EARLY_PHASE1 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Neoplasm Metastasis 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 4Nivolumab 4Magnetic Resonance Spectroscopy 4Temozolomide 2Specimen Handling 2Rituximab 2Radiotherapy 2Radiosurgery 2Paclitaxel 2Neoadjuvant Therapy 2Gemcitabine 2Dexamethasone 2Cisplatin 2Carboplatin 2venetoclax 1theanine 1temsirolimus 1tafasitamab 1sugemalimab 1senicapoc 1sacituzumab govitecan 1ruxolitinib 1perampanel 1paricalcitol 1pamiparib 1olaparib 1lutetium Lu 177 dotatate 1irinotecan sucrosofate 1glofitamab 1gadobutrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Radiosurgery × 30 days × Clear all
NCT04895592 2026-05-14

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Emory University

Phase EARLY_PHASE1 Completed
26 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT07128355 2026-05-13

Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Massachusetts General Hospital

Phase EARLY_PHASE1 Recruiting
15 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡